Cancer in Crohn's Disease

Gastroenterology Clinics of North America

Volumn 35, Issue 3, 2006, Pages 621-639

  Friedman, Sonia ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; IMMUNOMODULATING AGENT; MERCAPTOPURINE;

ADENOCARCINOMA; ANUS FISTULA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CARCINOID SYNDROME; COLORECTAL CANCER; COLORECTAL SURGERY; COMPARATIVE STUDY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONFIDENCE INTERVAL; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; ENTERITIS; GASTROINTESTINAL ENDOSCOPY; HEALTH SURVEY; HODGKIN DISEASE; HUMAN; ILEOSTOMY; LYMPHOMA; METASTASIS; ONSET AGE; POPULATION RESEARCH; POPULATION RISK; REVIEW; RISK ASSESSMENT; SMALL INTESTINE CANCER; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; ULCERATIVE COLITIS;

COLONOSCOPY; CROHN DISEASE; EPIDEMIOLOGIC STUDIES; HUMANS; INTESTINAL NEOPLASMS; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 33748098858     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2006.07.008     Document Type: Review

References (102)

1. Warren S., and Sommers S.C. Cicatrizing enteritis as a pathological entity. Am J Pathol 24 (1948) 475-501
2. Cooper D.J., Weinstein M.A., and Korelitz B.I. Complications of Crohn's disease predisposing to dysplasia and cancer of the intestinal tract: considerations of a surveillance program. J Clin Gastroenterol 6 3 (1984) 217-224
3. Craft C.F., Mendelsohn G., Cooper H.S., et al. Colonic "precancer" in Crohn's disease. Gastroenterology 80 3 (1981) 578-584
4. Darke S.G., Parks A.G., Grogono J.L., et al. Adenoma, carcinoma and Crohn's disease. A report of two cases and analysis of the literature. Br J Surg 60 3 (1973) 169-175
5. Dobbins III W.O. Dysplasia and malignancy in inflammatory bowel disease. Annu Rev Med 35 (1984) 33-48
6. Farmer R.G., Hawk W.A., and Turnbull Jr. R.B. Carcinoma associated with mucosal ulcerative colitis, and with transmural colitis and enteritis (Crohn's disease). Cancer 28 2 (1971) 289-292
7. Gyde S.N., Prior P., Macartney J.C., et al. Malignancy in Crohn's disease. Gut 21 12 (1980) 1024-1029
8. Hamilton S.R. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology 89 2 (1985) 398-407
9. Kraft S.C. Crohn's disease and digestive tract cancer. Gastroenterology 81 3 (1981) 626-627
10. Petras R.E., Mir-Madjlessi S.H., and Farmer R.G. Crohn's disease and intestinal carcinoma. A report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 93 6 (1987) 1307-1314
11. Ribeiro M.B., Greenstein A.J., Sachar D.B., et al. Colorectal adenocarcinoma in Crohn's disease. Ann Surg 223 2 (1996) 186-193
12. Richards M.E., Rickert R.R., and Nance F.C. Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann Surg 209 6 (1989) 764-773
13. Warren R., and Barwick W. Crohn's colitis with carcinoma and dysplasia. Report of a case and review of 100 small and large bowel resections for Crohn's disease to detect incidence of dysplasia. Am J Surg 7 (1983) 151-159
14. Korelitz B.I. Carcinoma of the intestinal tract in Crohn's disease: results of a survey conducted by the National Foundation for Ileitis and Colitis. Am J Gastroenterol 78 1 (1983) 44-46
15. Bernstein C.N., Blanchard J.F., Kliewer E., et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91 4 (2001) 854-862
16. Bernstein D., and Rogers A. Malignancy in Crohn's disease. Am J Gastroenterol 91 3 (1996) 434-440
17. Ekbom A., Helmick C., Zack M., et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 336 8711 (1990) 357-359
18. Fireman Z., Grossman A., Lilos P., et al. Intestinal cancer in patients with Crohn's disease. A population study in central Israel. Scand J Gastroenterol 24 3 (1989) 346-350
19. Gollop J.H., Phillips S.F., Melton III L.J., et al. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 29 1 (1988) 49-56
20. Jess T., Winther K.V., Munkholm P., et al. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 19 3 (2004) 287-293
21. Mellemkjaer L., Johansen C., Gridley G., et al. Crohn's disease and cancer risk (Denmark). Cancer Causes Control 11 2 (2000) 145-150
22. Persson P.G., Karlen P., Bernell O., et al. Crohn's disease and cancer: a population-based cohort study. Gastroenterology 107 6 (1994) 1675-1679
23. Fielding J.F., Prior P., Waterhouse J.A., et al. Malignancy in Crohn's disease. Scand J Gastroenterol 7 1 (1972) 3-7
24. Greenstein A.J., Sachar D.B., Smith H., et al. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 48 12 (1981) 2742-2745
25. Kvist N., Jacobsen O., Norgaard P., et al. Malignancy in Crohn's disease. Scand J Gastroenterol 21 1 (1986) 82-86
26. Friedman S., Rubin P.H., Bodian C., et al. Screening and surveillance colonoscopy on chronic Crohn's colitis. Gastroenterology 120 (2001) 820-826
27. Weedon D.D., Shorter R.G., Ilstrup D.M., et al. Crohn's disease and cancer. N Engl J Med 289 21 (1973) 1099-1102
28. Munkholm P., Langholz E., Davidsen M., et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 105 (1993) 1716-1723
29. Connell W.R., Sheffield J.P., Kamm M.A., et al. Lower gastrointestinal malignancy in Crohn's disease. Gut 35 3 (1994) 347-352
30. Gillen C.D., Andrews H.A., Prior P., et al. Crohn's disease and colorectal cancer. Gut 35 5 (1994) 651-655
31. Jess T., Loftus E., Velayos F., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted, Minnesota. Gastroenterology 130 (2006) 1039-1046
32. Jess T., Gamborg M., Matzen P., et al. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100 12 (2005) 2724-2729
33. Canavan C., Abrams K.R., and Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23 (2006) 1097-1104
34. Gillen C.D., Walmsley R.S., Prior P., et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35 11 (1994) 1590-1592
35. Stahl T.J., Schoetz D.J., Roberts P.L., et al. Crohn's disease and carcinoma: increasing justification for surveillance?. Dis Colon Rectum 35 (1992) 850-856
36. Morson B.C., and Pang L.A. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 8 (1967) 423-434
37. Simpson S., Traube J., and Riddell R.H. The histologic appearance of dysplasia (precarcinomatous change) in Crohn's disease of the small and large intestine. Gastroenterology 81 3 (1981) 492-501
38. Sigel J.E., Petras R.E., Lashner B.A., et al. Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia. Am J Surg Pathol 23 6 (1999) 651-655
39. Ullman T.A. Dysplasia and colorectal cancer in Crohn's disease. J Clin Gastroenterol 36 5 Suppl (2003) S75-S78 [discussion S94-6]
40. Itzkowitz S.H., and Present D.H. Consensus conference: Colorectal Cancer Screening and Surveillance in Inflammatory Bowel Disease. Inflamm Bowel Dis 11 3 (2005) 314-321
41. Yamazaki Y., Ribeiro M.B., Sachar D.B., et al. Malignant colorectal strictures in Crohn's disease. Am J Gastroenterol 86 (1991) 882-885
42. Greenstein A.J., Sachar D., Pucillo A., et al. Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg 135 1 (1978) 86-90
43. Choi P.M., and Zelig M.P. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35 7 (1994) 950-954
44. Corman M.L., Veidenheimer M.C., and Coller J.A. Colorectal carcinoma: a decade of experience at the Lahey Clinic. Dis Colon Rectum 22 (1979) 477-479
45. DeLeon M.L., Schoetz Jr. D.J., Coller J.A., et al. Colorectal cancer: Lahey Clinic Experience, 1972-1976. An analysis of prognostic indicators. Dis Colon Rectum 30 (1987) 237-242
46. Askling J., Dickman P.W., Karlen P., et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 120 6 (2001) 1356-1362
47. Lewis J.D., Deren J.J., and Lichtenstein G.R. Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am 28 2 (1999) 459-477
48. Palascak-Juif V., Bouvier A.M., Cosnes J., et al. Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo. Inflamm Bowel Dis 11 9 (2005) 828-832
49. Greenstein A.J., Sachar D.B., Smith H., et al. Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer 46 2 (1980) 403-407
50. Abrahams N.A., Halverson A., Fazio V.W., et al. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 45 11 (2002) 1496-1502
51. Collier P.E., Turowski P., and Diamond D.L. Small intestinal adenocarcinoma complicating regional enteritis. Cancer 55 3 (1985) 516-521
52. Lashner B. Risk factors for small bowel cancer in Crohn's disease. Dig Dis Sci 37 (1992) 1179-1184
53. Solem C.A., Harmsen W.S., Zinsmeister A.R., et al. Small intestinal adenocarcinoma in Crohn's disease: a case-control study. Inflamm Bowel Dis 10 1 (2004) 32-35
54. Ky A. Carcinomas arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum 41 (1998) 992-996
55. Greenstein A.J. Cancer in inflammatory bowel disease. Mt Sinai J Med 67 3 (2000) 227-240
56. Greenstein A.J., Gennuso R., Sachar D., et al. Extraintestinal cancers in inflammatory bowel disease. Cancer 56 (1985) 2914-2921
57. Bahadursingh A.M., and Longo W.E. Malignant transformation of chronic perianal Crohn's fistula. Am J Surg 189 1 (2005) 61-62
58. Buchman P., Allan R.N., Thompson H., et al. Carcinoma in a rectovaginal fistula in a patient with Crohn's disease. Am J Surg 140 (1980) 462-463
59. Buchman A.L., Ament M.E., and Doty J. Development of squamous cell carcinoma in chronic perineal sinus and wounds in Crohn's disease. Am J Gastroenterol 86 (1991) 1829-1832
60. Church J.M., Weakley F.L., Fazio V.W., et al. The relationship between fistulas in Crohn's disease and associated carcinoma: report of four cases and review of the literature. Dis Colon Rectum 28 (1985) 361-366
61. Devroe H., Coene L., Mortelmans L.J., et al. Colloid carcinoma arising in an anorectal fistula in Crohn's disease: a case report. Acta Chir Belg 105 1 (2005) 110-111
62. Ficari F., Fazi M., Garcea A., et al. Anal carcinoma occurring in Crohn's disease patients with chronic anal fistula. Suppl Tumori 4 3 (2005) S31
63. Fox L.P., Pasternack F.R., Geyer A.S., et al. Perineal squamous cell cancer in a patient with fistulizing and ulcerating Crohn's disease. Clin Exp Dermatol 30 6 (2005) 718-719
64. Laurent S., Barneaux A., Detroz B., et al. Development of adenocarcinoma in chronic fistula in Crohn's disease. Acta Gastroenterol Belg 68 1 (2005) 98-100
65. Moore-Maxwell C.A., and Robboy S.J. Mucinous adenocarcinoma arising in rectovaginal fistulas associated with Crohn's disease. Gynecol Oncol 93 1 (2004) 266-268
66. Nikias G., Eisner T., Katz S., et al. Crohn's disease and colorectal carcinoma: rectal cancer complicating long-standing perianal disease. Am J Gastroenterol 90 (1995) 216-219
67. Preston D.M., Fowler E.F., Lennard-Jones J.E., et al. Carcinoma of the anus in Crohn's disease. Br J Surg 70 (1983) 346-347
68. Sjodahl R.I., Myrelid P., and Soderholm J.D. Anal and rectal cancer in Crohn's disease. Colorectal Dis 5 5 (2003) 490-495
69. Zagoni T., Peter Z., Sipos F., et al. Carcinoma arising in enterocutaneous fistulae of Crohn's disease patients: description of two cases. Int J Colorectal Dis 18 (2005) 1-4
70. Bargen J. Chronic ulcerative colitis associated with malignant disease. Arch Surg 93 (1928) 1307-1311
71. Arseneau K.O., Stukenborg G.J., Connors Jr. A.F., et al. The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients. Inflamm Bowel Dis 7 2 (2001) 106-112
72. Askling J., Brandt L., Lapidus A., et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54 5 (2005) 617-622
73. Collins W.J. Malignant lymphoma complicating regional enteritis: case report and review of the literature. Am J Gastroenterol 68 2 (1977) 177-181
74. Ekbom A. Extracolonic malignancies in Crohn's disease. Cancer 67 (1991) 2015-2019
75. Freeman H.J. Tabulation of myeloid, lymphoid and intestinal malignancies in Crohn's disease. Can J Gastroenterol 16 11 (2002) 779-784
76. Greenstein A.J., Mullen G.E., Strauchen J.A., et al. Lymphoma in inflammatory bowel disease. Cancer 69 (1992) 1119-1123
77. Kwon J.H., and Farrell R.J. The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. Crit Rev Oncol Hematol 56 1 (2005) 169-178
78. Lewis J.D., Bilker W.B., Brensinger C., et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121 5 (2001) 1080-1087
79. Loftus Jr. E.V., Tremaine W.J., Habermann T.M., et al. Risk of lymphoma in inflammatory bowel disease. Am J Gastroenterol 95 9 (2000) 2308-2312
80. Losco A., Gianelli U., Cassani B., et al. Epstein-Barr virus-associated lymphoma in Crohn's disease. Inflamm Bowel Dis 10 4 (2004) 425-429
81. Aithal G.P., and Mansfield J.C. Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment. Aliment Pharmacol Ther 15 8 (2001) 1101-1108
82. Biancone L., Orlando A., Kohn A., et al. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut 55 2 (2006) 228-233
83. Bickston S.J., Lichtenstein G.R., Arseneau K.O., et al. The relationship between infliximab treatment and lymphoma in Crohn's disease. Gastroenterology 117 6 (1999) 1433-1437
84. Brown S.L., Greene M.H., Gershon S.K., et al. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 46 12 (2002) 3151-3158
85. Connell W.R., Kamm M.A., Dickson M., et al. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 343 8908 (1994) 1249-1252
86. Dayharsh G.A., Loftus Jr. E.V., Sandborn W.J., et al. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology 122 1 (2002) 72-77
87. Fraser A.G., Orchard T.R., Robinson E.M., et al. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 16 7 (2002) 1225-1232
88. Kandiel A., Fraser A.G., Korelitz B.I., et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 54 8 (2005) 1121-1125
89. Korelitz B.I., Mirsky F.J., Fleisher M.R., et al. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 94 11 (1999) 3248-3253
90. Lewis J.D., Schwartz J.S., and Lichtenstein G.R. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. Gastroenterology 118 6 (2000) 1018-1024
91. Present D.H., Meltzer S.J., Krumholz M.P., et al. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 111 8 (1989) 641-649
92. Makarem J.A., Otrock Z.K., Sharara A.I., et al. Crohn's disease in leukemia: report of a case, with a review of the literature. Dig Dis Sci 50 10 (2005) 1950
93. Hebbar M., Kozlowski D., Wattel E., et al. Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature. Leukemia 11 (1997) 2188-2191
94. Casellote J., Porta F., Tuset E., et al. Crohn's disease and the myelodysplastic syndrome. J Clin Gastroenterol 24 4 (1997) 286-287
95. Eng C., Farraye F., Shulman L.N., et al. The association between the myelodysplastic syndromes and Crohn's disease. Ann Intern Med 117 (1992) 661-662
96. Bosch X., Bernadich O., and Vera M. The association between Crohn's disease and the myelodysplastic syndromes: report of 3 cases and review of the literature. Medicine 77 6 (1998) 371-377
97. Harewood G.C., Loftus E.V., Tefferi A., et al. Concurrent inflammatory bowel disease and myelodysplastic syndromes. Inflamm Bowel Dis 5 2 (1999) 98-103
98. Brown G.A., Kollin J., and Rajan R.K. The coexistence of carcinoid tumor and Crohn's disease. J Clin Gastroenterol 82 (1986) 286-289
99. Cioffi U., De Simone M., Ferrero S., et al. Synchronous adenocarcinoma and carcinoid tumor of the terminal ileum in a Crohn's disease patient. BMC Cancer 5 (2005) 157
100. Freeman H.J. Appendiceal carcinoids in Crohn's disease. Can J Gastroenterol 17 1 (2003) 43-46
101. Greenstein A.J., Balasubramanian S., Harpaz N., et al. Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol 92 4 (1997) 682-685
102. Moertel C.G., Dockerty M.B., and Judd E.S. Carcinoid tumors of the vermiform appendix. Cancer 21 (1968) 270-278